Abstract
Prospective observational analysis of the efficacy and safety of low-dose (3 mg/kg) infliximab in ankylosing spondylitis: 4-year followup.
Stephanie Keeling, Anna Oswald, Anthony S Russell and Walter P Maksymowych
The Journal of Rheumatology March 2006, 33 (3) 558-561;
Stephanie Keeling
Anna Oswald
Anthony S Russell
In this issue
Prospective observational analysis of the efficacy and safety of low-dose (3 mg/kg) infliximab in ankylosing spondylitis: 4-year followup.
Stephanie Keeling, Anna Oswald, Anthony S Russell, Walter P Maksymowych
The Journal of Rheumatology Mar 2006, 33 (3) 558-561;